Genetically determined obesities, involving leptin-and melanocortin-signaling pathways, have focused attention on the four medial hypothalamic nuclei as primary sources of feeding-and metabolicallybased obesity. All four medial cell groups contain leptin receptors. To determine which of these cell groups normally mediates the effects of leptin on food intake and body weight gain, we injected colchicine bilaterally into each nucleus and determined the pathophysiological effects of disruption and responsivity to leptin injected intracerebroventricularly. Intracerebroventricular injections of leptin in shamlesioned rats decreased food intake during the dark period, but not during the light period. Lesions of the arcuate (ARC), paraventricular (PVN), and ventromedial (VMN) nuclei all resulted in leptin insensitivity; by contrast, lesions of the dorsomedial nuclei (DMN) augmented sensitivity to leptin on feeding and body weight gain. Although rats with ARC and PVN lesions were obese, they were still capable of reducing caloric efficiency over the 5 days of study and increasing uncoupling protein content in interscapular brown adipose tissue. Caloric efficiency and uncoupling protein content were unchanged in rats with VMN and DMN lesions. Finally, the slope of the relationship between leptin and mesenteric white adipose tissue was increased in rats with VMN lesions and abolished in rats with ARC lesions. Thus, lesions of the ARC, PVN, and VMN produced obesity via separate pathways. We conclude that the medial hypothalamic cell groups, each with a different role in energy balance, are all necessary for normal leptin responsiveness. (Endocrinology 140: 4426 -4433, 1999) E NERGY homeostasis, which is a balance among energy intake, metabolism, storage, and expenditure, is a complex regulatory function, mainly performed by the hypothalamus (1). Disruption of any of these components of energy balance can lead to pathologies ranging from wasting disorders or anorexia to obesity, which is a major health problem emerging in modern societies (2). Although every subdivision of the hypothalamus may contribute to the regulation of energy balance, four nuclei in the medial hypothalamus, the paraventricular (PVN), arcuate (ARC), ventromedial (VMN), and dorsomedial (DMN) nuclei, are certainly major contributors. These four cell groups receive signals of energy status, including leptin, which is a peptide synthesized and released by adipose tissue that binds the long form of leptin receptors (Ob-Rb) (3).
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Recent studies of rodent obesity models resulting from genetic mutations have clearly demonstrated that both leptin (4) and melanocortins (5, 6) are important signaling systems for regulating energy homeostasis. Melanocortins are peptide products cleaved from the POMC protein that bind to melanocortin-4 receptors (7). Leptin appears to act as a feedback signal and alters the synthesis and secretion of critical regulators of energy balance such as neuropeptide Y (NPY) and POMC-derived peptides (Fig. 1) . In leptin-deficient obese rodents, NPY is increased, and POMC is decreased in the arcuate (8) . However, POMC in the arcuate may have a greater regulatory role in energy balance than NPY, as destruction of the ARC by neonatal administration of the excitotoxin, monosodium glutamate, which reduces the number of both arcuate NPY (orexigenic signal) and POMC (anorexigenic signal) neurons, results in obesity (9) . Intracerebroventricular injections of leptin have been shown to decrease food intake, body weight, and NPY content in the ARC, PVN, and DMN nuclei and increase uncoupling protein (UCP) messenger RNA in brown adipose tissue (BAT) (10, 11) . Moreover, the effects of leptin on energy balance are enhanced when leptin is directly injected into the VMN (12) and to an even greater extent when it is injected into the ARC (13) . These studies combined with the fact that leptin receptors are found in various hypothalamic cell groups (3) demonstrate that leptin may have different roles in the regulation of energy balance depending on the site of action.
Several genetic models of obesity demonstrate that the closely apposed cell groups in the medial hypothalamus are critical sites of action for signals of energy status. However, critical for delineating the mechanisms of energy regulation is the demonstration of the downstream consequences of those signals. Although leptin receptors are found in several medial hypothalamic cell groups, only VMN lesions have been combined with acute intracerebroventricular (icv) injections of leptin (12) . Thus, our goal was to measure the effects of a single icv injection of leptin after colchicine lesions to the PVN, VMN, ARC, or DMN as well as to compare feeding and metabolic patterns after such lesions.
The close physical proximity of the medial hypothalamic cell groups makes it difficult to lesion each site selectively to determine its functional role(s) in the regulation of energy balance. Electrolytic or neurochemical lesions (14) are most often not confined to the nucleus of interest. By contrast, small volumes of colchicine can be injected selectively within the boundaries of specific cell groups (Fig. 2) where the agent is taken up by neurons (15) and subsequently disrupts function (16) .
Materials and Methods
We used adult male Sprague Dawley rats (Bantin & Kingman, Fremont, CA), weighing 200 -240 g. Animals were singly housed and maintained on a 12-h light, 12-h dark cycle (lights on 0700 h) and had free access to Purina rat chow (5008, Ralston Purina Co., St. Louis, MO) and water. Food and water consumption and body weights were measured at 0900 and 1700 h, 2 days before surgery and for 5 days after surgery. Food consumption was calculated by weighing food placed into food bins and subtracting the weight of the noningested and spilled food at the end of each measurement period. The experiments and procedures were approved by the University of California San Francisco committee on animal research.
Surgery
Animals were anesthetized with a rodent cocktail consisting of ketamine-xylazine-acepromazine (77:1.5:1.5 mg/kg; 1 ml/kg, ip) and placed in a stereotaxic apparatus. Each midline hypothalamic site was bilaterally injected using a Hamilton microsyringe (25 gauge) under anesthesia on day 0 with either a solution of colchicine (1 g/0.1 l) mixed with fluorescein-colchicine (Molecular Probes, Inc., Eugene, OR) or saline (0.1 l). Fluorescein-colchicine is inactive, but was used to determine the placement of injection sites and estimate the spread of injectate. Bilateral injections of either drug or vehicle were made in the ARC (n ϭ 22), VMN (n ϭ 25), PVN (n ϭ 17), and DMN (n ϭ 23) using coordinates based on the atlas of Paxinos and Watson (17) . The upper incisor bar was positioned at Ϫ3.3 mm below horizontal zero, and the following stereotaxic coordinates were used for the four hypothalamic cell groups: from bregma: VMN: anterior/posterior (AP), Ϫ2.5 mm; medial/lateral (ML), Ϯ0.7 mm; dorsal/ventral (DV), 9. At the time of hypothalamic injections, a 22-gauge guide cannula (Plastics One, Roanoke, VA) was implanted into a lateral ventricle for subsequent icv injection of 3 g leptin or vehicle (3 l) on postsurgical day 1.
Sample collection
On postsurgical day 5, blood samples were taken in the morning (0900 -1030 h) by decapitation. Trunk blood (5 ml) was collected in tubes containing 0.3 m disodium EDTA (100 l/tube). Brains were immediately postfixed in 10% formalin for 24 h and then stored in a 30% sucrose solution. Brains were sliced at 30 m, and the tip of the injection needle was localized in cresyl violet-stained sections; fluorescence from injected fluorescein-colchicine was localized in adjacent sections (Fig. 2 ). Rats were included in the study only if the needle tip was clearly directed at the intended nucleus, and fluorescence was within the borders of the cell group and did not extend to neighboring groups of interest. In addition to blood samples and brains, we collected interscapular BAT (iBAT) and white adipose tissue (WAT) from perirenal, epididymal, sc (inguinal), and mesenteric sites. BAT was collected and cleaned of WAT for measurement of UCP content.
RIAs
Blood samples were centrifuged at 3000 rpm at 4 C to separate plasma, which was subsequently stored at Ϫ20 C. Plasma insulin and leptin were measured using rat insulin and leptin RIA kits (Linco Research, Inc., St. Charles, MO). UCP was measured as previously (18), using reagents provided by Dr. Jean Himms-Hagen, University of Ottawa (Ottawa, Canada).
Statistical analysis
Data were analyzed using ANOVA corrected for repeated measures (when required). Scheffe analysis was used to test the significance of post-hoc effects. Regression analysis with slope comparisons was used to test the effects of colchicine disruption on the relationship of circulating leptin to fat mass. StatView (SAS Institute, Inc., Carey, NC) was the commercial statistical package used for all analyses.
Results

Control animals
Previously we have shown that vehicle injected into the four hypothalamic cell groups does not affect energy balance in rats (19) ; therefore, in these experiments we planned to combine all of the rats with vehicle injections into a single reference control group. Saline injections into the four hypothalamic nuclei (n ϭ 8/cell group; four given saline and four given leptin icv on day 1) did not cause site-specific effects, and the results were pooled (Fig. 3) . Compared with icv saline injections, icv leptin caused a decrease in both body weight gain (by ANOVA, P Ͻ 0.001 for time and time ϫ injection interaction) and food intake (by ANOVA, P Ͻ 0.01 for icv injection, time, and injection ϫ time interaction). Leptin injected icv on day 1 reduced dark period food intake on days 2 and 3 and decreased body weight on days 1.5-4 compared with saline-injected (icv) control values (by posthoc test, P Ͻ 0.05). Leptin did not significantly decrease sc fat depot weight on day 5, but did reduce caloric efficiency only on day 1, the day of injection (P Ͻ 0.05). Leptin had no effect on the thermogenic UCP content of iBAT on day 5. UCP increases thermogenesis, and thus decreases caloric efficiency (20) .
Lesioned animals
By contrast, colchicine injected into the ARC, PVN, or VMN on day 0 resulted in increased food intake, body weight (compared with saline-injected control rats; Fig. 3 , left half) and fat depots, as previously observed (19) . Leptin injected on day 1 did not affect any of these colchicine-injected groups (Fig. 4 , left half, columns 1 and 2). Because food intake was increased only during the light period in rats with VMN lesions and tended to decrease during the dark period, there was no significant cumulative increase in food intake in these rats (by repeated measures ANOVA, P ϭ 0.66), although cumulative food intake was significantly increased in rats with ARC and PVN lesions (by ANOVA: lesion, P Ͻ 0.0003; time, P Ͻ 0.0001; lesion ϫ time interaction, P Ͻ 0.0001 for both). Rats with DMN lesions exhibited marked decreases in food intake after leptin injection (by ANOVA: leptin, P Ͻ 0.05; time, P Ͻ 0.0001; leptin ϫ time interaction, P Ͻ 0.0001) and body weight (by ANOVA: time, P Ͻ 0.0001; leptin ϫ time interaction, P Ͻ 0.0001) after leptin injections (Fig. 4 , bottom left half). Subcutaneous fat depot weights (Fig. 4 , third column) were increased in rats with ARC, PVN, and VMN lesions (P Ͻ 0.05 all three) and were not affected by leptin injections (not shown in Fig. 4 ). Although rats with DMN lesions did not have increased fat weight compared with sham-lesioned controls, they did respond to leptin injection with a significant decrease in sc fat compared with saline-lesioned controls (P Ͻ 0.03; not shown). All lesioned rats, regardless of icv saline or leptin injections, had significantly increased plasma . n ϭ at least 5 rats/group. Columns and measures are explained in Fig. 2 . Fat depot, caloric efficiency, and UCP content compare salineto colchicine-injected rats (light stipple and dark stipple, respectively) with the results from icv leptin-and saline-injected groups pooled. In the caloric efficiency column, the asterisk represents significant differences (P Ͻ 0.05) between colchicine-injected (dark stipple) and salineinjected rats (not shown).
FIG. 5. Plasma leptin and insulin concentrations collected on day 5 are significantly elevated in all rats injected with colchicine compared with those in rats given saline (sham) on day 0 (P Ͻ 0.05). Results from groups injected on day 1 with icv saline or leptin did not differ, and the data were pooled (n ϭ 9 -32/group).
insulin and leptin levels ( Fig. 5 ; P Ͻ 0.05) compared with sham-lesioned animals.
Rats with lesions of the ARC, PVN, and VMN that resulted in the similar outcome of obesity (Fig. 4, columns 1-3 ) differed in their responses to the signals of obesity. Caloric efficiency progressively decreased over days 1-4 in rats with ARC and PVN lesions regardless of whether they had received icv leptin (by ANOVA: time, P Ͻ 0.0001). By contrast, caloric efficiency did not change in rats with VMN or DMN lesions with or without leptin (Fig. 4, fourth column) . This unresponsiveness in caloric efficiency, after VMN and DMN lesions, was not a function of exogenous leptin, as results very similar to these have been reported in a separate experiment on different animals in which the same four lesions were made without icv cannulation and leptin injections (19) . UCP content in iBAT (Fig. 4 , right column) increased in rats with ARC and PVN lesions, probably accounting in part for the decreased caloric efficiency in these rats [the increase in UCP was significant (P Ͻ 0.01) in ARC-lesioned and borderline (P ϭ 0.1) in PVN-lesioned rats). Outflow of the sympathetic nervous system is primarily responsible for changes in iBAT UCP content (20) , suggesting that the ARC-and PVN-lesioned groups, which are capable of responding to increased energy stores with increased UCP content, both still receive signals of energy stores and can act appropriately in response to those signals. Clearly, ARC and PVN lesions, which blocked decreases in food intake and body weight gain after icv leptin injections, did not block responses to signals of excess energy, although they appeared to be unresponsive to leptin per se. By contrast, obese rats with VMN lesions did not respond with significant changes in caloric efficiency or UCP content in iBAT to either saline or leptin, suggesting that this group either does not detect or does not respond to signals of elevated energy stores.
Disruption of the medial hypothalamic cell groups produced distinct changes not only in caloric efficiency but also in the relationship between fat mass and leptin. The relationship between mesenteric fat mass and circulating leptin in all sham-lesioned rats is shown in Fig. 6 . A slope of approximately 0.9 and 34% of the variance in leptin accounted for by the equation reflect the well described direct relationship that exists between fat mass and the hormone it secretes (21) . In colchicine-injected rats, compared with saline-injected sham animals, the relationship between mesenteric fat mass and leptin changes, particularly after ARC and VMN disruption (Fig. 7) . After ARC disruption, leptin concentrations are elevated and unrelated to fat mass; there is a calculated slope of 2.26, but only 10% of the variance in leptin is accounted for by the equation (P ϭ 0.396). After VMN disruption, there is a much steeper slope of the relation of leptin to fat mass than after sham lesion or any other nuclear disruption; in this group, the slope of the relationship increased to 5.3, and approximately 72% of the variance in leptin is accounted for by the equation (P Ͻ 0.001). After both PVN and DMN disruption, the relation of leptin to fat mass tended to increase, but not as dramatically as after VMN disruption; the slopes were approximately 1.9, and 39 -48% of the variance in leptin was accounted for (P Ͻ 0.01 for both). These altered slopes after nuclear disruption also held for the relationships of leptin to perirenal and epididymal fat masses (not shown).
Discussion
In sham-lesioned rats, body weight, food intake, and caloric efficiency were acutely and transiently decreased after an icv injection of leptin, and there were no lasting effects on energy balance, as fat depot weights and iBAT UCP content were not altered 4 days after the leptin injection. However, the diurnal pattern of feeding demonstrates a striking shift after icv leptin injection, in which only dark period feeding is decreased and light period feeding is unaltered compared with those in saline-injected rats. This result confirms the findings reported by Hulsey et al. (22) , who demonstrated that an icv injection of leptin altered meal patterns by decreasing meal duration selectively during the dark (not the light) period without producing a conditioned taste aversion. It is interesting that nocturnally active rats consume the majority of their food during the dark period, but, paradoxically, plasma leptin levels are also at their peak during the dark (23) . This apparent conflict between peak leptin secretion and peak food intake occurring at similar times of day suggests that important lags may occur between the action of leptin on its receptors and subsequent downstream effects.
Lesions of the ARC, PVN, and VMN produced obese rats, which, compared with sham-lesioned controls, had increased signals of excess energy (8) , as shown by elevated plasma leptin and insulin concentrations on day 5. Although lesions of all three cell groups produced obesity, ARC and PVN lesions produced different changes in feeding patterns compared with VMN lesions. ARC and PVN lesions increased food intake during both dark and light periods, whereas lesions of the VMN resulted in increased food intake only during the light period and a tendency for reduced feeding during the dark period, confirming our previous experiments (19) . Increases in body weight and food intake after lesions of the ARC, PVN, or VMN were not altered by the acute icv injection of leptin. Although the action of leptin on food intake was blocked by both ARC and VMN lesions, lesions of the ARC may mediate a greater role in the regulation of food intake by leptin. In sham-lesioned animals, icv leptin selectively decreased feeding during the dark, and lesions of the ARC, but the not the VMN, produced changes in dark period feeding. Previous studies have also shown that bilateral injections of leptin into the ARC are more effective in reducing food intake and body weight gain than injections into the VMN (13). Furthermore, it seems likely that POMC-derived MSH peptides mediate much of the feeding, body weight, and UCP responses to leptin, as injections of a melanocortin receptor antagonist inhibits the effects of leptin (10) . It is likely that ARC pathways to both VMN (24) and PVN (25) are activated by an action of leptin at the ARC, thus causing both sympathetic and behavioral effects (see Fig. 1 ). By contrast, DMN lesions resulted in increased sensitivity to icv leptin. This probably results from blockade of signals from cell groups in the lateral hypothalamus that contain orexigenic peptides (26) , which innervate the dorsomedial nuclei either directly (27) or indirectly through ARC and PVN pathways (26, 28) to modulate medial hypothalamic control of energy balance.
Arcuate lesions result in the loss of NPY and POMC neuronal activity, and paraventricular lesions result in the loss in action of NPY and POMC products. Thus, both lesions would be expected to produce similar effects on food intake. In support of this hypothesis, we have reported that small knife cuts placed between the ARC and PVN, which deprive the PVN of some innervation from ARC, also result in elevated food intake, during both light and dark periods, similar to the effects of either ARC or PVN lesions (29) . Moreover, a significant percentage of the variance in food intake in those rats is explained by the inverse relationship between food intake and the amount of ␣MSH (POMC product) detected in the PVN by immunocytochemical staining (Bell, M. E., unpublished). The current results combined with the effects of a PVN-ARC knife cut suggest that it is the removal of a tonic inhibitory input from ARC to PVN nuclei that results in increased food intake, in accord with the obesity-causing effects of melanocortin 4 receptor knockouts (6) .
However, ARC lesions can be distinguished from PVN lesions. Differences between ARC and PVN lesions can be found in altered relationships among circulating leptin concentrations, fat mass, and insulin. After ARC disruption, there is no relationship between fat mass and circulating leptin or between insulin and leptin (19) , suggesting either that those leptin receptors that respond acutely to peripheral leptin input are blocked or that ARC efferents have major autonomic effects. Systemically injected labeled leptin localizes only in the ARC, median eminence, and choroid plexus (30) . Based on the results of ARC lesions, it appears that systemic leptin signals are not heeded, given the lack of relationship of leptin to either fat mass or insulin. Alternatively, it is possible that direct or, more likely, indirect projections from the ARC normally participate in the autonomic regulation of leptin secretion from fat as well as the regulation of insulin secretion. In vitro studies have demonstrated that norepinephrine inhibits leptin secretion from adipose cells (31) . ARC lesions may abolish the normal noradrenergic regulation of leptin secretion from fat, thereby eliminating the relationship between leptin and fat mass. Dysregulation of insulin secretion resulting from ARC lesions (possibly through lack of signaling to the VMN) could abolish the relationship between leptin and insulin. PVN disruption only slightly increased the slope of the leptin-fat relationship, suggesting that after inactivating the PVN, the leptin signal is still recognized (perhaps by ARC), but that a small change in the efferent control of leptin secretion occurs.
Disruption of the PVN and ARC can also be differentiated by the subsequent changes in the leptin-insulin relationship. Our previous studies demonstrated that ARC disruption abolished the normal relationship between leptin and insulin, whereas the slope of the relationship increased after PVN and DMN disruption (19) . It seems reasonable to conclude that occupied leptin receptors in ARC regulate energy balance in PVN and elsewhere, and that when the axonal output of cells bearing these receptors is blocked by colchicine, the peripheral leptin-signaling system on NPY (11, 32)-and POMC (10, 33)-synthesizing cells is disabled.
Although three of the four hypothalamic nuclei, when inhibited, cause obesity and insensitivity to icv leptin, there are clear differences in the capacity of the energy expenditure systems to respond to this inhibition. The response to obesity resulting from overeating in rats with ARC and PVN lesions was a progressive decrease in caloric efficiency and either an increase or a tendency for an increase in iBAT UCP. This suggests strongly that the activity in neither ARC nor PVN is required for the energetic response to increased signals of energy stores. On the other hand, VMN-inhibited rats that were also obese did not respond with changes in either caloric efficiency or UCP, suggesting that the VMN and/or DMN are required for this energetic response. Because DMN inhibition did not result in obesity, it is unclear how to interpret the lack of change in caloric efficiency or UCP in these essentially normal rats. Lesions of the VMN inhibit sympathetic outflow (1) . The changes in caloric efficiency and UCP observed after ARC and PVN lesions, but not after VMN lesions, suggest strongly that activity in VMN is responsible for this adjustment to overeating. It is clear that the decreased food intake and body weight gain after icv leptin does not require DMN activity, as these were exaggerated by DMN inhibition. Thus, leptin reception at the DMN is not essential for these responses, and the major effect of DMN inhibition was to augment the responsivity of the rats to icv leptin.
Our studies, using small injection volumes of colchicine, distinguish between feeding and metabolic mechanisms that produce obesity induced by the inhibition of specific hypothalamic nuclei. Our previous studies have shown that both the concentration of colchicine and the volume of injectate must be small to confine the effects to a single nucleus (15) . Others, using higher concentrations and larger injection volumes of colchicine into the VMN, did not find the marked selectivity on food intake that we observed (34) . We suspect that the larger volume and concentration of colchicine used in those studies may have spilled over from the target VMN and blocked function in other cell groups, such as the ARC.
Obesity induced by alterations in function in or communication with PVN can be blocked by limiting caloric intake to that of normal rats (35) . By contrast, obesity caused by inhibiting the VMN is metabolic and is not reversed by food restriction (35) . Our data not only demonstrate that PVN and VMN lesions result in feeding and metabolically-dependent obesity, respectively, but that responsivity to signals of excess energy, such as leptin, is also dependent on functional activity of specific medial hypothalamic cell groups. There is strong conservation of hypothalamic neuro-and chemical anatomy between rodents and man (26) . Thus, if human obesity is derived from altered activity in structures functionally analogous to the rat ARC and PVN, one would predict that with a good deal of will power and reduced food intake, normal energy stores could be regained. However, this study suggests strongly that after VMN disruption, rats are no longer capable of responding to increased signals of energy stores with decreased caloric efficiency and increased thermogenesis to the signals of obesity. Because the VMN amplify circadian rhythms induced by the circadian clock in the suprachiasmatic nuclei (36) , this raises the possibility that aging in some individuals, accompanied by both damped circadian rhythms (37) and progressive obesity (38) , may in part be ascribed to uncoupling and relative insensitivity of VMN neurons to signals of metabolism and the circadian cycle. In this case, nutritional control would help, but not overcome, the tendency toward obesity.
